| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 59.00K | 0.00 | 25.00M | 925.00K | 144.00K | 0.00 |
| Gross Profit | -210.00K | -460.00K | 24.77M | 915.00K | 139.00K | -693.00K |
| EBITDA | -9.54M | -13.85M | 10.20M | -9.18M | -11.71M | -18.34M |
| Net Income | -10.04M | -14.47M | 9.52M | -10.14M | -8.21M | -11.13M |
Balance Sheet | ||||||
| Total Assets | 1.88M | 5.88M | 4.02M | 1.75M | 3.44M | 4.46M |
| Cash, Cash Equivalents and Short-Term Investments | 901.00K | 4.92M | 2.56M | 109.00K | 1.03M | 1.63M |
| Total Debt | 3.13M | 3.86M | 5.41M | 5.15M | 3.76M | 4.22M |
| Total Liabilities | 48.77M | 52.29M | 43.54M | 52.44M | 48.22M | 48.28M |
| Stockholders Equity | -49.84M | -46.41M | -39.52M | -50.69M | -44.78M | -43.82M |
Cash Flow | ||||||
| Free Cash Flow | -5.20M | -3.22M | 10.79M | -2.96M | -7.71M | -4.78M |
| Operating Cash Flow | -5.23M | -3.22M | 10.79M | -2.96M | -7.70M | -4.78M |
| Investing Cash Flow | -51.00K | 0.00 | -2.00K | -4.00K | -3.00K | -1.00K |
| Financing Cash Flow | 5.36M | 5.57M | -8.34M | 2.04M | 7.11M | 6.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | $33.61M | -2.84 | ― | ― | ― | 39.36% | |
47 Neutral | $42.73M | -1.47 | ― | ― | -38.72% | 16.01% | |
46 Neutral | $103.99M | -2.79 | -8.46% | ― | -7.79% | 10.04% | |
43 Neutral | $90.12M | ― | -18.19% | ― | 2.80% | ― | |
43 Neutral | $63.38M | -1.42 | ― | ― | -46.98% | -186.82% | |
42 Neutral | $21.71M | -0.22 | -936.03% | ― | ― | ― |
On November 24, 2025, ParkerVision, Inc. completed the sale of 16,481,579 shares of its common stock to accredited investors, raising approximately $3.46 million. This transaction, part of a registered direct offering under the company’s shelf registration, contributes to a total of $4.46 million raised, including a previous sale to a director. The sale supports ParkerVision’s ongoing operations and patent enforcement efforts.
On November 21, 2025, ParkerVision, Inc. entered into subscription agreements with accredited investors to sell 16,481,579 shares of its common stock at $0.21 per share, totaling approximately $3.46 million. The transaction, expected to close on November 24, 2025, was conducted as a registered direct offering without an underwriter, utilizing the company’s existing shelf registration statement filed with the SEC.
On November 17, 2025, ParkerVision, Inc. completed a direct offering of 4,761,905 shares of its common stock to Lewis H. Titterton, Jr., a director of the company, for $1,000,000. The shares were sold at $0.21 each, matching the last reported sale price on the OTCQB Venture Market. This transaction, conducted under the company’s shelf registration statement, marks the only use of the shelf to date and highlights ParkerVision’s strategic financial maneuvers to bolster its capital without incurring additional costs from intermediaries.
On November 14, 2025, ParkerVision, Inc. entered into a subscription agreement with Lewis H. Titterton, Jr., a director of the company, for the purchase of 4,761,905 shares of common stock at $0.21 per share, totaling $1,000,000. This transaction, expected to close by November 18, 2025, was approved by disinterested board members and is part of the company’s existing shelf registration, potentially impacting its financial standing and shareholder dynamics.